newsfilter
← Latest News
Business Wire·

AGC Biologics Supports Commercial Production of Provention Bio's New Type 1 Diabetes (T1D) Therapy, TZIELD™

The Global CDMO's Seattle site continues work on this new T1D treatment, the first and only treatment approved to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D